Our findings reveal that XIST/miR-130a-3p/ALK2 axis may play a crucial role in the progression of T2D and that targeting this axis may be an effective strategy for treating patients with T2D. This evidence concerns the gene ACVR1 and type 2 diabetes mellitus.